Consolidated Statement of Changes in Shareholders' (Deficit) Equity - USD ($) |
Total |
Accrued Unpaid Interest |
Bonus Share |
Conversion Features Six |
Conversion Features Seven |
Conversion Features Eight |
Exercise Price 1 |
Exercise Price 2 |
Conversion Features one |
Conversion Features two |
Conversion Features three |
Conversion Features Four |
Conversion Features Five |
Preferred Stock |
Common Stock |
Common Stock
Accrued Unpaid Interest
|
Common Stock
Bonus Share
|
Common Stock
Conversion Features Six
|
Common Stock
Conversion Features Seven
|
Common Stock
Conversion Features Eight
|
Common Stock
Exercise Price 1
|
Common Stock
Exercise Price 2
|
Common Stock
Conversion Features one
|
Common Stock
Conversion Features two
|
Common Stock
Conversion Features three
|
Common Stock
Conversion Features Four
|
Common Stock
Conversion Features Five
|
Common Stock Payable |
Common Stock Payable
Accrued Unpaid Interest
|
Common Stock Payable
Bonus Share
|
Additional Paid-in Capital |
Rescission Amount |
Accumulated Deficit |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beginning balance at May. 31, 2013 | $ (223,916) | $ 274,091 | $ 16,144,673 | $ 117,778 | $ 17,778,861 | $ (536,500) | $ (34,002,819) | ||||||||||||||||||||||||||
Beginning balance, shares at May. 31, 2013 | 95,100 | 30,908,292 | |||||||||||||||||||||||||||||||
Rescission expirations and exclusions | 158,500 | 158,500 | |||||||||||||||||||||||||||||||
Amortization of deferred offering costs related to rescission liability | (28,636) | $ (7,840) | $ (20,796) | ||||||||||||||||||||||||||||||
Proceeds from unit offering, shares | 20,989,494 | ||||||||||||||||||||||||||||||||
Common shares issued to extinguish promissory notes payable, convertible debt and related interest, shares | 2,046,148 | 1,493,333 | 24,363 | 16,117 | 21,963 | ||||||||||||||||||||||||||||
Proceeds from unit offering, value | 13,642,667 | $ 13,642,667 | |||||||||||||||||||||||||||||||
Common shares issued to extinguish promissory notes payable, convertible debt and related interest, value | 2,459,000 | $ 1,330,000 | $ 1,120,000 | $ 15,837 | $ 12,088 | $ 10,012 | $ 1,330,000 | $ 1,120,000 | $ 15,837 | $ 12,088 | $ 10,012 | ||||||||||||||||||||||
Deferred offering costs | (2,084,063) | $ (2,084,063) | |||||||||||||||||||||||||||||||
Inducement interest on reissued warrants | 193,160 | 193,160 | |||||||||||||||||||||||||||||||
Exercise of common stock warrants, shares | 50,000 | ||||||||||||||||||||||||||||||||
Common stock issuable, share | 150,000 | 53,601 | |||||||||||||||||||||||||||||||
Exercise of common stock warrants, Value | 50,000 | $ 50,000 | |||||||||||||||||||||||||||||||
Common stock issuable, value | $ 64,722 | $ 35,139 | $ 75,000 | $ 72,361 | $ (10,278) | $ (107,500) | |||||||||||||||||||||||||||
Stock-based compensation | 928,413 | 928,413 | |||||||||||||||||||||||||||||||
Debt discount related to warrants and beneficial conversion feature associated with convertible debt | 1,200,000 | 1,200,000 | |||||||||||||||||||||||||||||||
Net loss at year ended | (12,431,413) | (12,431,413) | |||||||||||||||||||||||||||||||
Ending Balance at May. 31, 2014 | 3,922,232 | $ 266,251 | $ 30,367,779 | 20,100,434 | (378,000) | (46,434,232) | |||||||||||||||||||||||||||
Ending balance, shares at May. 31, 2014 | 95,100 | 55,753,311 | |||||||||||||||||||||||||||||||
Rescission expirations and exclusions | 378,000 | $ 378,000 | |||||||||||||||||||||||||||||||
Amortization of deferred offering costs related to rescission liability | (68,292) | $ (18,695) | $ (49,597) | ||||||||||||||||||||||||||||||
Common shares issued to extinguish promissory notes payable, convertible debt and related interest, shares | 104,153 | 5,628,330 | 119,580 | ||||||||||||||||||||||||||||||
Common shares issued to extinguish promissory notes payable, convertible debt and related interest, value | 4,221,250 | $ 52,077 | $ 4,221,250 | $ 86,296 | $ 52,077 | $ 4,221,250 | $ 86,296 | ||||||||||||||||||||||||||
OID, intrinsic value related to warrants | 2,505,261 | 2,505,261 | |||||||||||||||||||||||||||||||
Inducement interest on reissued warrants | 970,367 | 970,367 | |||||||||||||||||||||||||||||||
Exercise of common stock warrants, shares | 1,938,974 | 100,000 | |||||||||||||||||||||||||||||||
Exercise of common stock warrants, Value | $ 1,066,435 | $ 75,000 | $ 1,066,435 | $ 75,000 | |||||||||||||||||||||||||||||
Stock-based compensation | 631,302 | 631,302 | |||||||||||||||||||||||||||||||
Inducement interest on note conversions and warrant exercises | 555,626 | 555,626 | |||||||||||||||||||||||||||||||
Net loss at year ended | (25,088,070) | (25,088,070) | |||||||||||||||||||||||||||||||
Ending Balance at May. 31, 2015 | $ (10,692,516) | $ 247,556 | $ 35,819,240 | $ 24,762,990 | $ (71,522,302) | ||||||||||||||||||||||||||||
Ending balance, shares at May. 31, 2015 | 95,100 | 63,644,348 |